Peregrine Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-301,068
| Closed | -$1.84M | – | 326 |
|
|
2023
Q1 | $1.84M | Buy |
301,068
+8,903
| +3% | +$54.4K | 0.05% | 246 |
|
|
2022
Q4 | $1.87M | Buy |
292,165
+50,671
| +21% | +$324K | 0.06% | 242 |
|
|
2022
Q3 | $2.31M | Sell |
241,494
-13,318
| -5% | -$128K | 0.07% | 244 |
|
|
2022
Q2 | $2.81M | Sell |
254,812
-2,964
| -1% | -$32.7K | 0.08% | 248 |
|
|
2022
Q1 | $4.29M | Buy |
257,776
+5,926
| +2% | +$98.7K | 0.1% | 249 |
|
|
2021
Q4 | $4.81M | Buy |
251,850
+46,016
| +22% | +$878K | 0.1% | 248 |
|
|
2021
Q3 | $5.08M | Sell |
205,834
-40,748
| -17% | -$1M | 0.11% | 247 |
|
|
2021
Q2 | $6.42M | Buy |
246,582
+10,398
| +4% | +$271K | 0.12% | 255 |
|
|
2021
Q1 | $7.48M | Sell |
236,184
-33,045
| -12% | -$1.05M | 0.14% | 250 |
|
|
2020
Q4 | $12.5M | Sell |
269,229
-101,839
| -27% | -$4.73M | 0.24% | 204 |
|
|
2020
Q3 | $12.2M | Sell |
371,068
-35,333
| -9% | -$1.16M | 0.32% | 115 |
|
|
2020
Q2 | $11.2M | Buy |
406,401
+26,983
| +7% | +$741K | 0.32% | 121 |
|
|
2020
Q1 | $11.4M | Sell |
379,418
-162,558
| -30% | -$4.87M | 0.41% | 105 |
|
|
2019
Q4 | $15M | Sell |
541,976
-101,439
| -16% | -$2.81M | 0.38% | 116 |
|
|
2019
Q3 | $11.7M | Sell |
643,415
-14,236
| -2% | -$259K | 0.32% | 127 |
|
|
2019
Q2 | $16.1M | Sell |
657,651
-173,864
| -21% | -$4.26M | 0.4% | 109 |
|
|
2019
Q1 | $7.91M | Buy |
+831,515
| New | +$7.91M | 0.2% | 203 |
|